• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞中铁的结合形式及螯合疗法的化学特性。

Forms of iron binding in the cells and the chemical features of chelation therapy.

作者信息

Puntarulo S, Galleano M

机构信息

Physical Chemistry-PRALIB, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.

出版信息

Mini Rev Med Chem. 2009 Aug;9(9):1136-46. doi: 10.2174/138955709788922674.

DOI:10.2174/138955709788922674
PMID:19689409
Abstract

Iron is essential for human life, however it can be toxic through Fe ability to generate oxygen-derived radicals. This work reviews the main features of Fe binding in the cell and its association to these processes. The chemical nature of the Fe extracted by chelation therapy in pathophysiological situations is also analyzed.

摘要

铁对人类生命至关重要,然而,由于铁具有产生氧衍生自由基的能力,它可能具有毒性。本文综述了细胞中铁结合的主要特征及其与这些过程的关联。同时也分析了病理生理情况下螯合疗法所提取的铁的化学性质。

相似文献

1
Forms of iron binding in the cells and the chemical features of chelation therapy.细胞中铁的结合形式及螯合疗法的化学特性。
Mini Rev Med Chem. 2009 Aug;9(9):1136-46. doi: 10.2174/138955709788922674.
2
Chemical features of in use and in progress chelators for iron overload.用于铁过载的正在使用和正在研发的螯合剂的化学特性。
J Trace Elem Med Biol. 2016 Dec;38:10-18. doi: 10.1016/j.jtemb.2016.05.010. Epub 2016 Jun 9.
3
Iron Chelation for Iron Overload in Thalassemia.地中海贫血铁过载的铁螯合治疗
Met Ions Life Sci. 2019 Jan 14;19. doi: 10.1515/9783110527872-009.
4
Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeutics.1-(2-羟乙氧基)甲基-2-烷基-3-羟基-4-吡啶酮的无环核苷铁螯合剂:潜在的口服铁螯合治疗药物。
Nucleosides Nucleotides Nucleic Acids. 2004;23(3):599-611. doi: 10.1081/NCN-120030718.
5
Iron chelation.
J Assoc Physicians India. 1991 Sep;39(9):665-6.
6
The medicinal chemistry of novel iron chelators for the treatment of cancer.新型铁螯合剂的药物化学及其在癌症治疗中的应用。
Curr Top Med Chem. 2011;11(5):483-99. doi: 10.2174/156802611794785190.
7
Iron: a new target for pharmacological intervention in neurodegenerative diseases.铁:神经退行性疾病药物干预的新靶点。
Semin Pediatr Neurol. 2006 Sep;13(3):186-97. doi: 10.1016/j.spen.2006.08.008.
8
Iron chelation, angiogenesis and tumor therapy.
Int J Cancer. 2003 Sep 1;106(3):458-9. doi: 10.1002/ijc.11223.
9
The kinetics of dimethylhydroxypyridinone interactions with iron(iii) and the catalysis of iron(iii) ligand exchange reactions: implications for bacterial iron transport and combination chelation therapies.二羟甲基吡啶酮与铁(III)的相互作用动力学及铁(III)配体交换反应的催化:对细菌铁转运和组合螯合疗法的影响。
Dalton Trans. 2018 May 22;47(20):6954-6964. doi: 10.1039/c8dt01329b.
10
Oral iron chelators--development and application.
Best Pract Res Clin Haematol. 2002 Jun;15(2):369-84. doi: 10.1016/s1521-6926(02)90209-4.

引用本文的文献

1
Reestablishment of ischemia-reperfusion liver injury by N-acetylcysteine administration prior to a preconditioning iron protocol.在预处理铁方案之前给予N-乙酰半胱氨酸可重建缺血再灌注肝损伤。
ScientificWorldJournal. 2013 Oct 27;2013:607285. doi: 10.1155/2013/607285. eCollection 2013.
2
Recent advances in liver preconditioning: Thyroid hormone, n-3 long-chain polyunsaturated fatty acids and iron.肝脏预处理的最新进展:甲状腺激素、n-3长链多不饱和脂肪酸与铁
World J Hepatol. 2012 Apr 27;4(4):119-28. doi: 10.4254/wjh.v4.i4.119.